Latest Administration News

La Trobe Financial Asset Management has launched a Distribution Reinvestment Plan (DRP) for its Private Credit Fund, offering unitholders a streamlined way to reinvest cash distributions into additional units without brokerage fees.

Macarthur Minerals has acknowledged breaching ASX conditions by issuing equity securities without approval and will seek shareholder consent to amend terms and comply with listing rules.

Ignite Limited (ASX, IGN) has re-established its Dividend Reinvestment Plan, offering Australian and New Zealand shareholders a flexible, cost-free way to reinvest dividends into additional shares. The Board retains discretion over discount application and participation terms.

The Star Entertainment Group is asking shareholders to approve a $400 million strategic investment package critical to its survival, involving convertible notes from Bally's and its largest shareholder. This move aims to secure the company’s future amid ongoing legal challenges and financial strain.

Solis Minerals has voluntarily delisted from the TSX Venture Exchange to concentrate on its primary ASX listing, prompting changes to its ASX waivers and financial reporting calendar.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

Cyprium Metals has obtained crucial environmental and operational approvals to advance the phased redevelopment of its Nifty Copper Complex, setting the stage for a near-term production restart.

Zeotech Limited’s Preliminary Feasibility Study (PFS) for its AusPozz™ Project reveals a robust business case for Australia’s first metakaolin production facility, promising strong financial returns and significant carbon emission reductions.

eMetals Limited reveals a significant 300-meter-wide gold-in-soil anomaly at its Busia Gold Project in Uganda, highlighting promising early exploration results within a highly prospective greenstone belt.

Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.

Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.

Ronin Resources Limited updates ASX on delayed exploration activities and relinquished projects, citing socio-political challenges and market conditions. The company anticipates key licence grants by August 2025 and confirms compliance with listing rules while seeking new opportunities.